Filing Flows › Lifevantage (LFVN) › Q3 2025
Lifevantage (LFVN) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 4, 2025
Lifevantage (LFVN) reported revenue of $47.6M for the third quarter 2025 (Q3 2025), +0.7% from a year earlier and -14% from the quarter before. Operating margin was 4.8%, net earnings $2.2M (4.5% of revenue).
Lifevantage, Q3 2025: revenue $47.6M (+0.7% year over year), operating margin 4.8%, net earnings $2.2M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $47.6M | -14% | +0.7% |
| Gross profit | $37.8M | -14% | +0.2% |
| Operating profit | $2.3M | +6% | -12% |
| Net earnings | $2.2M | +10% | +18% |
| Operating cash flow | −$2.3M | -323% | — |
What changed
Revenue was $47.6M in Q3 2025, up 1% year over year and down 14% from the previous quarter. Protandim was the largest line at 46% of revenue. TrueScience Product Line added $5.2M year over year (up 133%), 1499% of the total change. LifeVantage TrueScience Skin Care Regimen declined 23%.
Gross margin was 79.5%, down 0.4 points from a year earlier. Operating profit was $2.3M, a 4.8% margin (down 0.7 points year over year). Operating profit fell $302K even though revenue rose $347K versus a year earlier, so costs grew faster than sales. Operating expenses grew 1% against revenue growth of 1%. Net earnings were $2.2M, up 18% year over year. The effective tax rate was 3.8%.
Operating cash flow was −$2.3M. Non-cash charges added back $610K of depreciation and amortization and $826K of share-based compensation. Working capital and other items used $5.9M. Capital expenditures of $439K exceeded it, leaving free cash flow of −$2.7M.
Questions
What was Lifevantage's revenue in the third quarter 2025?
Lifevantage (LFVN) reported revenue of $47.6M for the third quarter 2025 (Q3 2025), +0.7% from a year earlier and -14% from the quarter before.
Was Lifevantage profitable in the third quarter 2025?
Operating profit was $2.3M (4.8% of revenue) and net earnings $2.2M.
Source: Lifevantage 10-Q on SEC EDGAR.